Dr. Stanley Shaw is the inaugural Associate Dean for Executive Education at Harvard Medical School. In this role, he designs and directs a growing portfolio of programs for companies and executive leaders from diverse sectors of health care, from small biotechs to Fortune 100 companies. Dr. Shaw is also the Chief Scientific Officer for One Brave Idea (at Brigham and Women’s Hospital), an initiative funded by the American Heart Association, Verily and Astra Zeneca to understand and treat the earliest changes in coronary heart disease. His research seeks to understand how digital health, bioinformatics, the gut microbiome and patient-reported data can be leveraged to better assess health and disease. Previously, he co-founded the Center for Assessment Technology and Continuous Health (CATCH) at Massachusetts General Hospital, and his team led the development of one of the first ResearchKit iPhone apps in partnership with Apple. Dr. Shaw received his AB in Chemistry & Physics from Harvard College, and his MD and PhD (in Biophysics) from Harvard. He completed his clinical training in Internal Medicine and Cardiology at Massachusetts General Hospital.